Agilent Technologies (NYSE:A) Issues FY25 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY25 earnings guidance on Monday morning. The company provided EPS guidance of $5.54-5.61 for the period, compared to the consensus EPS estimate of $5.65. The company issued revenue guidance of $6.79-6.87 billion, compared to the consensus revenue estimate of $6.82 billion. Agilent Technologies also updated its Q1 guidance to $1.25-1.28 EPS.

Agilent Technologies Stock Up 0.5 %

NYSE:A traded up $0.65 on Monday, hitting $134.49. 3,273,158 shares of the company’s stock traded hands, compared to its average volume of 1,720,104. The company has a market cap of $38.64 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 5.89 and a beta of 1.07. Agilent Technologies has a 1 year low of $124.10 and a 1 year high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The firm has a 50-day moving average price of $137.90 and a 200-day moving average price of $137.61.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.74%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Bank of America boosted their price target on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Citigroup lifted their price target on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Barclays raised their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. Stifel Nicolaus reissued a “buy” rating and issued a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. Finally, TD Cowen raised their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $144.36.

Insider Buying and Selling

In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.